This is a preview of subscription content, log in via an institution to check access.
Notes
incremental cost-effectiveness threshold
Reference
Sruamsiri R, et al. A Cost-effectiveness Study of Intravenous Immunoglobulin in Childhood Idiopathic Thrombocytopenia Purpura Patients with Life-Threatening Bleeding. PharmacoEconomics : 22 May 2014. Available from: URL: http://dx.doi.org/10.1007/s40273-014-0171-9
Rights and permissions
About this article
Cite this article
Immunoglobulin cost effective for childhood ITP in Thailand. PharmacoEcon Outcomes News 704, 5 (2014). https://doi.org/10.1007/s40274-014-1284-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1284-2